Our Team
Chiromesh Therapeutics is a U.S. early-stage biotech company, founded by global leaders in drug delivery, bioengineering and nanomedicine, cancer biology, neurosurgery, and immunotherapy
Our team is committed to designing and developing drug delivery platforms that precisely deploy advanced therapies, ensuring maximum benefit for each patient
Chiromesh Therapeutics, Inc. is incorporated in the State of Delaware and registered to operate in the State of California
Paolo Decuzzi, PhD
Founder & interim CEO
Senior Scientist and Professor
Nanotechnology for Precision Medicine
Italian Institute of Technology
Dean Felsher, MD PhD
Founder
Professor and Director
Translational Research Applied Medicine
Stanford University
Frederick Lang, MD
Founder
Professor and Chairman
Neurosurgery
MD Anderson Cancer Center
A Global Alliance
Chiromesh Therapeutics, Inc. is headquartered in Mountain View, CA, in the heart of Silicon Valley, with additional research laboratories and state-of-the-art facilities at Stanford University (CA), MD Anderson Cancer Center in Houston (TX); and the Italian Institute of Technology in Genoa (Italy)
µMESH is being developed by an interdisciplinary team of scientists, engineers, and physician adopting the most rigorous protocols and models
Chiromesh Therapeutics, Inc. benefits from its proximity to world-class research institutions and its ability to access diverse funding sources in California, Texas, the US, and Europe, which provides it with a strategic advantage
The design, development, and preclinical validation of µMESH have been supported by various governmental agencies and research foundations in Europe and North America, totaling over $3.0 million to date
